Send to

Choose Destination
Eur J Nucl Med Mol Imaging. 2015 Apr;42(4):634-43. doi: 10.1007/s00259-014-2974-5. Epub 2015 Jan 9.

Image-derived biomarkers and multimodal imaging strategies for lung cancer management.

Author information

Diagnostic and Interventional Radiology, Department of Radiology, Eberhard Karls University Tuebingen, Hoppe-Seyler-Str. 3, 72076, Tuebingen, Germany.


Non-small-cell lung cancer is the most common type of lung cancer and one of the leading causes of cancer-related death worldwide. For this reason, advances in diagnosis and treatment are urgently needed. With the introduction of new, highly innovative hybrid imaging technologies such as PET/CT, staging and therapy response monitoring in lung cancer patients have substantially evolved. In this review, we discuss the role of FDG PET/CT in the management of lung cancer patients and the importance of new emerging imaging technologies and radiotracer developments on the path to personalized medicine.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center